Go Pro
→ Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (From InvestorPlace) (Ad)tc pixel Free CELC Stock Alerts

Celcuity (CELC) Financials

Celcuity logo
$79.52 +0.15 (+0.19%)
Closing price 04:00 PM Eastern
Extended Trading
$79.56 +0.04 (+0.04%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Celcuity

Annual Income Statements for Celcuity

This table shows Celcuity's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -3.31 -6.25 -7.48 -7.36 -9.47 -30 -40 -64 -112 -177
Consolidated Net Income / (Loss)		 -3.31 -6.25 -7.48 -7.36 -9.47 -30 -40 -64 -112 -177
Net Income / (Loss) Continuing Operations		 -3.31 -6.25 -7.48 -7.36 -9.47 -30 -40 -64 -112 -177
Total Pre-Tax Income 		-3.31 -6.25 -7.48 -7.36 -9.47 -30 -40 -64 -112 -177
Total Operating Income		 -3.33 -5.95 -7.93 -7.81 -9.56 -28 -39 -66 -113 -172
Total Gross Profit		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Revenue		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Cost of Revenue		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Operating Expenses		 3.33 5.95 7.93 7.81 9.56 28 39 66 113 172
Selling, General & Admin Expense		 0.26 0.97 1.61 1.54 1.87 2.60 4.10 5.64 9.06 27
Research & Development Expense		 3.06 4.98 6.33 6.27 7.68 26 35 61 104 145
Total Other Income / (Expense), net		 0.02 -0.30 0.45 0.45 0.08 -1.25 -0.98 2.45 1.49 -4.85
Interest Expense		 0.00 0.45 0.00 0.00 0.00 1.26 2.11 5.33 10 17
Interest & Investment Income		 0.02 0.15 0.45 0.45 0.08 0.01 1.13 7.78 12 12
Income Tax Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Basic Earnings per Share		 ($0.52) ($0.84) ($0.74) ($0.72) ($0.92) ($2.21) ($2.64) ($2.69) ($2.83) ($3.79)
Weighted Average Basic Shares Outstanding		 6.31M 7.46M 10.12M 10.23M 10.27M 13.38M 15.42M 23.68M 39.45M 46.76M
Diluted Earnings per Share		 ($0.52) ($0.84) ($0.74) ($0.72) ($0.92) - ($2.64) ($2.69) ($2.83) ($3.79)
Weighted Average Diluted Shares Outstanding		 6.31M 7.46M 10.12M 10.23M 10.27M 13.38M 15.42M 23.68M 39.45M 46.76M
Weighted Average Basic & Diluted Shares Outstanding		 6.31M 7.46M 10.12M 10.23M 10.27M 13.38M 21.69M 30.45M 37.84M 48.34M

Quarterly Income Statements for Celcuity

This table shows Celcuity's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Total Costs & Expenses		 - - - - - - 44 - - - 66
Net Income / (Loss) Attributable to Common Shareholders		 -19 -22 -24 -30 -37 -37 -45 -44 -51 -53 -79
Consolidated Net Income / (Loss)		 -19 -22 -24 -30 -37 -37 -45 -44 -51 -53 -79
Net Income / (Loss) Continuing Operations		 -19 -22 -24 -30 -37 -37 -45 -44 -51 -53 -79
Total Pre-Tax Income 		-19 -22 -24 -30 -37 -37 -45 -44 -51 -53 -79
Total Operating Income		 -20 -22 -24 -30 -36 -36 -44 -43 -49 -51 -66
Total Gross Profit		 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00
Total Revenue		 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00
Total Cost of Revenue		 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00
Total Operating Expenses		 20 22 24 30 36 36 44 43 49 51 66
Selling, General & Admin Expense		 1.65 1.85 1.79 2.47 2.96 6.37 7.59 7.93 12 17 35
Research & Development Expense		 18 21 22 28 33 30 36 35 38 33 31
Total Other Income / (Expense), net		 0.88 0.88 0.56 0.27 -0.49 -0.86 -1.26 -0.96 -1.77 -2.33 -13
Interest Expense		 1.40 1.40 2.26 3.34 3.28 3.18 3.20 4.60 6.17 6.09 17
Interest & Investment Income		 2.28 2.28 2.82 3.61 3.05 2.32 1.95 3.64 4.39 3.75 4.15
Income Tax Expense		 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00
Basic Earnings per Share		 ($0.65) ($0.64) ($0.62) ($0.70) ($0.87) ($0.86) ($1.04) ($0.92) ($0.97) ($0.97) ($1.44)
Weighted Average Basic Shares Outstanding		 23.68M 33.61M 38.44M 42.79M 39.45M 43.05M 43.66M 47.59M 46.76M 54.46M 54.82M
Diluted Earnings per Share		 ($0.65) ($0.64) ($0.62) ($0.70) ($0.87) ($0.86) ($1.04) ($0.92) ($0.97) ($0.97) ($1.44)
Weighted Average Diluted Shares Outstanding		 23.68M 33.61M 38.44M 42.79M 39.45M 43.05M 43.66M 47.59M 46.76M 54.46M 54.82M
Weighted Average Basic & Diluted Shares Outstanding		 30.45M 31.23M 37.03M 37.13M 37.84M 37.87M 42.43M 46.27M 48.34M 48.77M 48.93M

Annual Cash Flow Statements for Celcuity

This table details how cash moves in and out of Celcuity's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 0.79 -3.22 13 2.79 -7.10 73 -60 6.09 -8.15 143
Net Cash From Operating Activities		 -2.89 -4.95 -6.08 -6.00 -7.15 -20 -36 -54 -83 -153
Net Cash From Continuing Operating Activities		 -2.89 -4.95 -6.08 -5.66 -7.15 -20 -36 -54 -83 -153
Net Income / (Loss) Continuing Operations		 -3.31 -6.25 -7.48 -7.36 -9.47 -30 -40 -64 -112 -177
Consolidated Net Income / (Loss)		 -3.31 -6.25 -7.48 -7.36 -9.47 -30 -40 -64 -112 -177
Depreciation Expense		 0.07 0.10 0.22 0.34 0.39 0.30 0.21 0.14 0.13 0.17
Amortization Expense		 - - - - 0.00 0.27 0.40 0.24 1.33 3.14
Non-Cash Adjustments To Reconcile Net Income		 0.19 1.33 1.25 1.08 1.74 7.90 4.95 5.72 19 23
Changes in Operating Assets and Liabilities, net		 0.16 -0.13 -0.07 -0.05 0.20 0.82 -1.19 3.86 8.11 -2.77
Net Cash From Investing Activities		 -0.04 -29 19 8.53 -0.09 -0.08 -144 -5.01 -63 -64
Net Cash From Continuing Investing Activities		 -0.04 -29 19 9.29 -0.09 -0.08 -144 -5.01 -63 -64
Purchase of Property, Plant & Equipment		 -0.04 -0.24 -0.63 -0.38 -0.09 -0.08 -0.16 -0.10 -0.25 -0.25
Purchase of Investments		 0.00 -29 -3.24 - - 0.00 -144 -315 -705 -396
Sale and/or Maturity of Investments		 - 0.00 23 8.91 - - 0.00 310 642 333
Net Cash From Financing Activities		 3.72 31 0.24 0.26 0.14 93 120 65 138 361
Net Cash From Continuing Financing Activities		 3.72 31 0.24 0.27 0.14 93 120 65 138 361
Issuance of Debt		 0.00 7.49 - - 0.00 - - 0.00 59 223
Issuance of Common Equity		 3.72 24 0.14 0.09 0.18 0.00 96 65 64 92
Other Financing Activities, net		 0.00 0.00 0.10 0.18 -0.04 79 4.92 0.36 15 46
Cash Interest Paid		 - - - - 0.00 0.69 1.26 3.27 7.59 10

Quarterly Cash Flow Statements for Celcuity

This table details how cash moves in and out of Celcuity's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents		 4.90 0.55 -0.76 -18 9.91 -6.04 30 28 91 -24 40
Net Cash From Operating Activities		 -19 -17 -18 -21 -28 -36 -36 -45 -36 -55 -55
Net Cash From Continuing Operating Activities		 -19 -17 -18 -21 -28 -36 -36 -45 -36 -58 -52
Net Income / (Loss) Continuing Operations		 -19 -22 -24 -30 -37 -37 -45 -44 -51 -53 -79
Consolidated Net Income / (Loss)		 -19 -22 -24 -30 -37 -37 -45 -44 -51 -53 -79
Depreciation Expense		 0.03 0.03 0.03 0.03 0.04 0.04 0.04 0.04 0.05 0.05 0.06
Amortization Expense		 0.06 0.07 0.24 0.48 0.55 0.55 0.54 0.78 1.27 1.25 1.21
Non-Cash Adjustments To Reconcile Net Income		 1.15 1.64 1.32 1.71 3.83 2.92 4.24 5.87 11 -6.50 21
Changes in Operating Assets and Liabilities, net		 -0.93 2.81 4.07 7.01 4.47 -2.69 4.24 -7.70 1.88 -0.23 3.96
Net Cash From Investing Activities		 -41 3.54 -106 1.90 38 24 66 -258 103 35 -331
Net Cash From Continuing Investing Activities		 -41 3.54 -106 1.90 38 24 66 -258 103 35 -331
Purchase of Property, Plant & Equipment		 -0.03 -0.09 -0.06 -0.05 -0.05 -0.06 -0.04 -0.10 -0.05 -0.29 -0.14
Purchase of Investments		 -130 -121 -241 -153 -190 -42 -64 -290 - -15 -445
Sale and/or Maturity of Investments		 89 125 135 155 227 67 130 32 103 50 115
Net Cash From Financing Activities		 65 14 123 0.80 0.12 5.55 0.23 330 24 0.03 423
Net Cash From Continuing Financing Activities		 65 14 123 0.80 0.12 5.55 0.23 330 24 0.03 423
Other Financing Activities, net		 0.21 14 0.40 0.82 -0.02 5.55 0.02 15 25 0.03 1.68
Cash Interest Paid		 0.87 0.87 1.63 2.61 2.47 2.38 2.42 2.62 2.93 5.89 3.55

Annual Balance Sheets for Celcuity

This table presents Celcuity's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 6.06 32 26 20 13 86 176 191 245 467
Total Current Assets		 5.91 24 25 19 12 85 175 191 245 466
Cash & Equivalents		 5.86 2.64 16 19 12 84 25 31 23 166
Short-Term Investments		 0.00 22 8.95 - - 0.00 144 150 213 276
Prepaid Expenses		 0.00 0.21 0.27 0.27 0.32 0.72 - - 6.77 19
Other Current Assets		 0.01 0.03 0.05 0.05 0.02 0.04 6.60 10 2.70 5.27
Plant, Property, & Equipment, net		 0.14 0.28 0.81 0.83 0.56 0.31 0.26 0.23 0.34 0.50
Total Noncurrent Assets		 0.00 7.21 0.00 0.20 0.23 0.24 0.25 0.40 0.22 0.40
Intangible Assets		 - - - - - - - - - 0.00
Other Noncurrent Operating Assets		 - - 0.00 0.20 0.23 0.24 0.25 0.40 0.22 0.40
Total Liabilities & Shareholders' Equity		 6.06 32 26 20 13 86 176 191 245 467
Total Liabilities		 0.45 0.58 0.68 0.98 1.25 17 42 51 130 366
Total Current Liabilities		 0.45 0.58 0.66 0.91 1.19 2.51 6.88 14 32 44
Accounts Payable		 0.33 0.07 0.12 0.14 0.22 1.51 2.63 5.08 9.37 6.41
Accrued Expenses		 0.11 0.51 0.54 0.58 0.77 0.80 4.06 8.93 17 22
Other Current Liabilities		 - - 0.01 0.18 0.19 0.20 0.19 0.18 5.65 16
Total Noncurrent Liabilities		 0.00 0.00 0.02 0.07 0.07 15 35 37 98 322
Long-Term Debt		 - - - - 0.00 15 35 37 98 322
Other Noncurrent Operating Liabilities		 - - 0.00 0.07 0.06 0.06 0.06 0.23 0.05 0.00
Commitments & Contingencies		 0.00 0.00 - - - 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 5.61 31 25 19 12 69 134 140 116 101
Total Preferred & Common Equity		 5.61 31 25 19 12 69 134 140 116 101
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 5.61 31 25 19 12 69 134 140 116 101
Common Stock		 14 33 35 36 38 125 230 300 387 549
Retained Earnings		 -8.33 -2.01 -9.49 -17 -26 -56 -96 -160 -272 -449

Quarterly Balance Sheets for Celcuity

This table presents Celcuity's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets		 165 154 142 188 293 273 218 184 476 410 828
Total Current Assets		 164 153 142 188 292 272 218 183 475 409 776
Cash & Equivalents		 34 32 26 31 30 13 16 46 74 145 182
Short-Term Investments		 124 114 108 146 253 251 189 122 381 242 572
Prepaid Expenses		 6.53 6.46 7.77 - - - - - - 15 13
Other Current Assets		 0.06 0.10 - 9.86 8.86 8.38 12 15 21 6.49 8.80
Plant, Property, & Equipment, net		 0.22 0.21 0.22 0.31 0.31 0.34 0.36 0.36 0.42 0.62 0.61
Total Noncurrent Assets		 0.55 0.50 0.45 0.35 0.31 0.26 0.17 0.13 0.09 0.62 52
Intangible Assets		 - - - - - - - - - - 50
Other Noncurrent Operating Assets		 0.55 0.50 0.45 0.35 0.31 0.26 0.17 0.13 0.09 0.62 1.77
Total Liabilities & Shareholders' Equity		 165 154 142 188 293 273 218 184 476 410 828
Total Liabilities		 42 43 49 54 116 123 131 139 359 357 841
Total Current Liabilities		 5.81 7.08 13 17 20 26 33 40 39 33 87
Accounts Payable		 2.57 3.02 5.63 5.28 6.20 9.16 9.93 11 11 10 8.09
Accrued Expenses		 3.04 3.87 6.89 11 13 17 23 29 27 8.77 58
Other Current Liabilities		 0.20 0.19 0.19 0.18 0.18 0.18 0.17 0.14 0.10 14 21
Total Noncurrent Liabilities		 36 36 37 38 96 97 99 99 320 323 754
Long-Term Debt		 35 36 37 38 96 97 99 99 320 323 753
Other Noncurrent Operating Liabilities		 0.36 0.32 0.27 0.18 0.14 0.10 0.01 0.00 0.00 - 0.89
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 123 110 93 134 177 150 87 44 117 54 -13
Total Preferred & Common Equity		 123 110 93 134 177 150 87 44 117 54 -13
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 123 110 93 134 177 150 87 44 117 54 -13
Common Stock		 231 233 234 315 382 385 396 398 515 555 568
Retained Earnings		 -108 -123 -141 -182 -205 -235 -309 -354 -398 -502 -581

Annual Metrics And Ratios for Celcuity

This table displays calculated financial ratios and metrics derived from Celcuity's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 - - - - - - - - - 46,271,259.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - 46,271,259.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - -3.83
Growth Metrics		 - - - - - - - - - -
Profitability Metrics		 - - - - - - - - - -
Net Operating Profit after Tax (NOPAT)		 -2.33 -4.17 -5.55 -5.46 -6.69 -20 -28 -46 -79 -121
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - -26.22% -37.16% -28.54%
Earnings before Interest and Taxes (EBIT)		 -3.33 -5.95 -7.93 -7.81 -9.56 -28 -39 -66 -113 -172
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -3.26 -5.85 -7.71 -7.47 -9.17 -28 -39 -66 -112 -169
Valuation Ratios		 - - - - - - - - - -
Leverage & Solvency		 - - - - - - - - - -
Liquidity Ratios		 - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -4.40 -6.09 -5.55 -6.20 -19 -29 -42 -61 -123
Efficiency Ratios		 - - - - - - - - - -
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 -0.29 -0.06 0.47 0.56 0.07 -0.95 0.17 -3.78 -22 -19
Increase / (Decrease) in Invested Capital		 0.00 0.23 0.53 0.09 -0.49 -1.02 1.11 -3.95 -18 2.67
Book Value per Share		 $0.89 $3.11 $2.50 $1.88 $1.14 $4.61 $8.65 $5.77 $3.11 $2.17
Tangible Book Value per Share		 $0.89 $3.11 $2.50 $1.88 $1.14 $4.61 $8.65 $5.77 $3.11 $2.17
Total Capital		 5.61 31 25 19 12 83 169 177 213 422
Total Debt		 0.00 0.00 0.02 0.00 0.01 15 35 37 98 322
Total Long-Term Debt		 0.00 0.00 0.02 0.00 0.01 15 35 37 98 322
Net Debt		 -5.91 -31 -25 -19 -12 -70 -134 -144 -137 -120
Capital Expenditures (CapEx)		 0.04 0.24 0.63 0.38 0.09 0.08 0.16 0.10 0.25 0.25
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -0.44 -0.34 -0.34 -0.40 -0.66 -1.44 -0.28 -4.18 -22 -20
Debt-free Net Working Capital (DFNWC)		 5.47 24 25 18 11 83 168 176 213 422
Net Working Capital (NWC)		 5.47 24 25 18 11 83 168 176 213 422
Net Nonoperating Expense (NNE)		 0.98 2.08 1.93 1.90 2.78 9.76 13 17 32 57
Net Nonoperating Obligations (NNO)		 -5.91 -31 -25 -19 -12 -70 -134 -144 -137 -120
Total Depreciation and Amortization (D&A)		 0.07 0.10 0.22 0.34 0.39 0.57 0.61 0.38 1.46 3.30
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.52) ($0.84) ($0.74) ($0.72) ($0.92) ($2.21) ($2.64) ($2.69) ($2.83) ($3.79)
Adjusted Weighted Average Basic Shares Outstanding		 6.31M 10.11M 10.21M 10.25M 10.30M 14.92M 15.42M 23.68M 39.45M 46.76M
Adjusted Diluted Earnings per Share		 ($0.52) ($0.84) ($0.74) ($0.72) ($0.92) ($2.21) $0.00 ($2.69) ($2.83) ($3.79)
Adjusted Weighted Average Diluted Shares Outstanding		 6.31M 10.11M 10.21M 10.25M 10.30M 14.92M 21.69M 23.68M 39.45M 46.76M
Adjusted Basic & Diluted Earnings per Share		 ($0.52) ($0.84) ($0.74) ($0.72) ($0.92) ($2.21) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 6.31M 7.46M 10.12M 10.23M 10.27M 13.38M 21.69M 30.45M 37.84M 48.34M
Normalized Net Operating Profit after Tax (NOPAT)		 -2.33 -4.17 -5.55 -5.46 -6.69 -20 -28 -46 -79 -121
Debt Service Ratios		 - - - - - - - - - -
Payout Ratios		 - - - - - - - - - -

Quarterly Metrics And Ratios for Celcuity

This table displays calculated financial ratios and metrics derived from Celcuity's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding		 - - - - - - - - 46,271,259.00 48,336,675.00 48,766,288.00
DEI Adjusted Shares Outstanding		 - - - - - - - - 46,271,259.00 48,336,675.00 48,766,288.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - -1.10 -1.09 -1.62
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
EBITDA Growth		 -71.08% -79.96% -60.54% -55.72% -82.53% -58.70% -80.85% -42.24% - -38.44% -49.30%
EBIT Growth		 -69.51% -79.27% -61.29% -57.64% -84.65% -60.64% -81.23% -42.54% - -39.78% -50.24%
NOPAT Growth		 -69.51% -79.27% -61.29% -59.06% -84.65% -60.64% -81.23% -42.54% - -39.78% -50.24%
Net Income Growth		 -62.75% -81.03% -62.62% -61.87% -94.46% -71.19% -90.83% -47.03% - -42.83% -74.22%
EPS Growth		 0.00% -16.36% 6.06% 15.66% -33.85% -34.38% -67.74% -31.43% - -12.79% -38.46%
Operating Cash Flow Growth		 -95.54% -32.64% -86.99% -61.31% -49.82% -110.06% -100.43% -117.96% - -53.59% -53.06%
Free Cash Flow Firm Growth		 -6.52% 31.67% 24.01% -6.76% 23.76% -36.75% -134.52% -263.73% - -309.97% -253.15%
Invested Capital Growth		 -2,361.88% -618.49% -8,002.71% -284.08% -475.90% -222.28% -142.73% -1.95% - 50.67% 45.06%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
EBITDA Q/Q Growth		 -4.44% -14.06% -7.21% -21.92% -22.42% 0.84% -22.19% 3.23% - -2.77% -31.78%
EBIT Q/Q Growth		 -4.40% -14.01% -7.95% -22.69% -22.28% 0.82% -21.80% 2.64% - -2.65% -30.91%
NOPAT Q/Q Growth		 -4.40% -14.01% -7.95% -23.79% -21.19% 0.82% -21.80% 2.64% - -2.65% -30.91%
Net Income Q/Q Growth		 -2.41% -14.66% -9.76% -25.59% -23.03% -0.94% -22.36% 3.23% - -3.66% -49.25%
EPS Q/Q Growth		 21.69% 1.54% 3.13% -12.90% -24.29% 1.15% -20.93% 11.54% - 0.00% -48.45%
Operating Cash Flow Q/Q Growth		 -45.42% 7.92% -5.85% -13.81% -35.06% -29.11% -1.00% -23.76% - -51.28% -0.66%
Free Cash Flow Firm Q/Q Growth		 -29.19% 17.29% 15.02% -17.59% 7.74% -48.33% -45.76% -82.36% - -23.26% -25.55%
Invested Capital Q/Q Growth		 16.73% -68.33% -60.24% -71.01% -24.86% 5.80% -20.68% 28.17% - 47.04% -34.41%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
EBITDA Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Operating Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
EBIT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Profit (Net Income) Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% - 100.00% 100.00%
Interest Burden Percent		 95.54% 96.08% 97.69% 100.00% 100.61% 102.39% 102.86% 102.23% - 104.62% 119.28%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Return on Equity (ROE)		 -46.63% -57.17% -57.59% -77.47% -87.54% -115.39% -134.54% -122.04% - -275.17% -1,433.70%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Return on Assets (ROA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Return on Common Equity (ROCE)		 -46.63% -57.17% -57.59% -77.47% -87.54% -115.39% -134.54% -122.04% - -275.17% -1,433.70%
Return on Equity Simple (ROE_SIMPLE)		 0.00% -54.92% -46.74% -62.77% 0.00% -146.73% 0.00% 0.00% - 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -14 -16 -17 -21 -26 -25 -31 -30 -34 -35 -46
NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)		 -3.64% -4.48% -4.53% -6.61% -7.94% -9.47% -11.30% -9.15% - -20.48% -93.20%
Return On Investment Capital (ROIC_SIMPLE)		 -7.81% - - - -11.95% -13.66% -21.45% -6.86% -8.15% -9.38% -6.25%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Operating Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)		 -20 -22 -24 -30 -36 -36 -44 -43 -49 -51 -66
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -20 -22 -24 -29 -36 -36 -43 -42 -48 -49 -65
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 2.52 4.92 2.90 3.69 4.20 4.41 11.39 17.92 - 103.08 0.00
Price to Tangible Book Value (P/TBV)		 2.52 4.92 2.90 3.69 4.20 4.41 11.39 17.92 - 103.08 0.00
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.27 0.28 0.54 0.65 0.85 1.14 2.24 2.74 - 6.04 -58.93
Long-Term Debt to Equity		 0.27 0.28 0.54 0.65 0.85 1.14 2.24 2.74 - 6.04 -58.93
Financial Leverage		 -1.01 -1.02 -1.04 -1.09 -1.10 -1.12 -1.16 -1.13 - -1.22 -2.21
Leverage Ratio		 1.34 1.37 1.56 1.71 1.71 1.84 2.15 2.81 - 4.48 32.03
Compound Leverage Factor		 1.28 1.32 1.52 1.71 1.72 1.89 2.22 2.87 - 4.69 38.20
Debt to Total Capital		 20.95% 21.93% 35.25% 39.30% 45.81% 53.20% 69.11% 73.25% - 85.80% 101.73%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Long-Term Debt to Total Capital		 20.95% 21.93% 35.25% 39.30% 45.81% 53.20% 69.11% 73.25% - 85.80% 101.73%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Common Equity to Total Capital		 79.05% 78.07% 64.75% 60.70% 54.19% 46.80% 30.89% 26.75% - 14.20% -1.73%
Debt to EBITDA		 -0.56 -0.50 -1.13 -1.01 -0.87 -0.79 -0.69 -2.04 - -1.77 -3.69
Net Debt to EBITDA		 2.18 1.85 2.20 1.75 1.23 0.86 0.48 0.86 - 0.35 0.00
Long-Term Debt to EBITDA		 -0.56 -0.50 -1.13 -1.01 -0.87 -0.79 -0.69 -2.04 - -1.77 -3.69
Debt to NOPAT		 -0.80 -0.70 -1.61 -1.43 -1.23 -1.11 -0.97 -2.87 - -2.48 -5.16
Net Debt to NOPAT		 3.10 2.63 3.13 2.47 1.73 1.21 0.67 1.21 - 0.49 0.01
Long-Term Debt to NOPAT		 -0.80 -0.70 -1.61 -1.43 -1.23 -1.11 -0.97 -2.87 - -2.48 -5.16
Altman Z-Score		 3.71 6.59 2.51 2.20 1.25 0.23 -0.38 3.14 - 8.26 3.39
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 13.43 11.23 14.95 10.36 7.71 6.61 4.58 12.26 - 12.31 8.93
Quick Ratio		 12.73 10.64 14.50 10.04 7.41 6.25 4.22 11.73 - 11.65 8.68
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -9.87 -8.16 -6.93 -8.15 -7.52 -11 -16 -30 -37 -46 -57
Operating Cash Flow to CapEx		 -56,686.51% -19,033.14% -28,109.63% -40,491.73% -61,507.42% -59,755.00% -92,851.28% -46,202.06% - -19,321.05% -40,754.41%
Free Cash Flow to Firm to Interest Expense		 -7.06 -5.83 -3.07 -2.44 -2.30 -3.51 -5.08 -6.45 - -7.52 -3.40
Operating Cash Flow to Interest Expense		 -13.27 -12.19 -7.99 -6.15 -8.48 -11.26 -11.30 -9.75 - -9.05 -3.28
Operating Cash Flow Less CapEx to Interest Expense		 -13.29 -12.25 -8.02 -6.16 -8.49 -11.28 -11.31 -9.77 - -9.10 -3.29
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -3.78 -6.36 -10 -17 -22 -20 -25 -18 -19 -10 -14
Invested Capital Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Increase / (Decrease) in Invested Capital		 -3.95 -7.59 -10 -13 -18 -14 -15 -0.34 2.67 10 11
Enterprise Value (EV)		 209 518 325 385 349 275 436 1,961 - 5,454 5,101
Market Capitalization		 353 658 512 552 486 383 506 2,096 - 5,517 5,102
Book Value per Share		 $5.77 $4.39 $5.66 $4.04 $3.11 $2.33 $1.17 $2.76 $2.17 $1.11 ($0.26)
Tangible Book Value per Share		 $5.77 $4.39 $5.66 $4.04 $3.11 $2.33 $1.17 $2.76 $2.17 $1.11 ($1.29)
Total Capital		 177 171 273 247 213 185 144 437 422 377 740
Total Debt		 37 38 96 97 98 99 99 320 322 323 753
Total Long-Term Debt		 37 38 96 97 98 99 99 320 322 323 753
Net Debt		 -144 -140 -187 -167 -137 -107 -69 -135 -120 -64 -0.81
Capital Expenditures (CapEx)		 0.03 0.09 0.06 0.05 0.05 0.06 0.04 0.10 0.05 0.29 0.14
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -4.18 -6.84 -11 -18 -22 -21 -25 -18 -20 -11 -65
Debt-free Net Working Capital (DFNWC)		 176 171 272 246 213 185 143 437 422 376 689
Net Working Capital (NWC)		 176 171 272 246 213 185 143 437 422 376 689
Net Nonoperating Expense (NNE)		 5.04 5.87 6.72 8.75 11 12 14 14 17 17 33
Net Nonoperating Obligations (NNO)		 -144 -140 -187 -167 -137 -107 -69 -135 -120 -64 -0.81
Total Depreciation and Amortization (D&A)		 0.09 0.09 0.27 0.51 0.59 0.59 0.58 0.82 1.32 1.30 1.27
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.65) ($0.64) ($0.62) ($0.70) ($0.87) ($0.86) ($1.04) ($0.92) ($0.97) ($0.97) ($1.44)
Adjusted Weighted Average Basic Shares Outstanding		 23.68M 33.61M 38.44M 42.79M 39.45M 43.05M 43.66M 47.59M 46.76M 54.46M 54.82M
Adjusted Diluted Earnings per Share		 ($0.65) ($0.64) ($0.62) ($0.70) ($0.87) ($0.86) ($1.04) ($0.92) ($0.97) ($0.97) ($1.44)
Adjusted Weighted Average Diluted Shares Outstanding		 23.68M 33.61M 38.44M 42.79M 39.45M 43.05M 43.66M 47.59M 46.76M 54.46M 54.82M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 30.45M 31.23M 37.03M 37.13M 37.84M 37.87M 42.43M 46.27M 48.34M 48.77M 48.93M
Normalized Net Operating Profit after Tax (NOPAT)		 -14 -16 -17 -21 -26 -25 -31 -30 -34 -35 -46
Normalized NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Pre Tax Income Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -14.12 -16.06 -10.74 -8.91 -11.12 -11.35 -13.74 -9.33 - -8.30 -3.91
NOPAT to Interest Expense		 -9.88 -11.24 -7.52 -6.29 -7.79 -7.95 -9.62 -6.53 - -5.81 -2.74
EBIT Less CapEx to Interest Expense		 -14.14 -16.12 -10.77 -8.92 -11.14 -11.37 -13.75 -9.35 - -8.35 -3.92
NOPAT Less CapEx to Interest Expense		 -9.91 -11.31 -7.55 -6.31 -7.80 -7.97 -9.63 -6.55 - -5.86 -2.75
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Celcuity’s financial statements show a well-funded but increasingly expensive development-stage business. The company has reported no revenue in the periods provided, while research and development spending, operating losses, cash burn and leverage have all increased. At the same time, significant debt and equity financing have substantially expanded its liquidity.

  • Liquidity increased substantially. As of June 30, 2026, Celcuity held $182.0 million in cash and $572.0 million in short-term investments, or approximately $754.0 million of liquid assets. This compares with approximately $168.4 million at June 30, 2025 and $263.5 million at June 30, 2024.
  • Financing activity provided a large capital cushion. Celcuity generated $422.9 million from financing activities in Q2 2026, and its long-term debt increased to $753.2 million from $323.4 million in Q1 2026. The additional capital may support clinical development and other growth initiatives.
  • Investment income is becoming a meaningful source of cash. Interest and investment income was $4.2 million in Q2 2026, up from $1.9 million in Q2 2024. The company’s sizable short-term investment portfolio should continue generating income, although that income remains far below its operating expenses.
  • Cash management has been active but volatile. Celcuity frequently buys, sells and matures short-term investments. Q2 2026 included $445.5 million of investment purchases and $115.0 million of sales or maturities, resulting in $330.6 million of investing cash outflow. These transactions primarily reflect portfolio management rather than operating growth.
  • Research and development remains the primary use of capital. R&D expense was $31.1 million in Q2 2026, representing nearly half of total operating expenses. This spending may support future product development, but the statements do not yet show commercial revenue to validate the investment.
  • Celcuity has not generated revenue in any reported quarter provided. Revenue and gross profit were both listed as zero in the quarters reviewed, leaving the company dependent on financing and investment income to fund operations.
  • Operating expenses and losses are accelerating. Q2 operating expenses rose from $24.3 million in 2024 to $44.0 million in 2025 and $66.1 million in 2026. Net loss widened over the same periods from $23.7 million to $45.3 million and then $78.9 million.
  • Operating cash burn has worsened steadily. Net cash used in operating activities increased from $18.1 million in Q2 2024 to $36.2 million in Q2 2025 and $55.4 million in Q2 2026. This trend indicates that liquidity could decline quickly if additional financing does not produce commercial progress.
  • Leverage and interest costs have risen sharply. Long-term debt increased from $96.2 million in Q2 2024 to $323.4 million in Q1 2026 and $753.2 million in Q2 2026. Quarterly interest expense reached $16.9 million in Q2 2026, compared with $2.3 million in Q2 2024, adding pressure to future cash flows.
  • Shareholder dilution and balance-sheet risk are significant. Weighted-average basic shares increased from 38.4 million in Q2 2024 to 54.8 million in Q2 2026. In addition, total shareholders’ equity declined from $176.7 million in Q2 2024 to negative $12.8 million in Q2 2026, as accumulated losses and higher liabilities more than offset the company’s assets.

Overall, Celcuity has a substantial liquidity reserve, but its financial profile remains high risk. The company’s ability to convert research spending into revenue, reduce operating cash burn and manage its sharply higher debt load will be central to the investment case.

09/25/26 09:57 PM ETAI Generated. May Contain Errors.

Celcuity Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Celcuity's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Celcuity's net income appears to be on a downward trend, with a most recent value of -$177.04 million in 2025, falling from -$3.31 million in 2016. The previous period was -$111.78 million in 2024. See Celcuity's forecast for analyst expectations on what's next for the company.

Celcuity's total operating income in 2025 was -$172.19 million, based on the following breakdown:
  • Total Gross Profit: $0.00
  • Total Operating Expenses: $172.19 million

Over the last 9 years, Celcuity's total revenue changed from $0.00 in 2016 to $0.00 in 2025, a change of 0.0%.

In the past 13 quarters, Celcuity's cash and equivalents has ranged from $12.60 million in Q3 2024 to $182.05 million in Q2 2026, and is currently $182.05 million as of their latest financial filing in Q2 2026.

Celcuity had total debt of $321.85 million at the end of 2025, a 229.3% increase from 2024, and none in 2016.

Over the last 9 years, Celcuity's book value per share changed from 0.89 in 2016 to 2.17 in 2025, a change of 144.5%.


Related Companies

Financial statements for NASDAQ:CELC last updated on 8/13/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Here’s Why Trump Won’t End The Iran War
Trump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...
Banyan Hill Publishing | Sponsoredtc pixel
These gold assets are priced for $1,800 gold [it's over $4,000]
Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...
Golden Portfolio | Sponsoredtc pixel
100% overnight gains?
Rumors are circulating that Elon Musk is preparing to acquire three publicly traded companies. Dr. Mark Sko...
The Oxford Club | Sponsoredtc pixel